-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Syros Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2021 to 2024.
- Syros Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending March 31, 2024 was -0.1 USD/shares, a 88.2% increase year-over-year.
- Syros Pharmaceuticals, Inc. Earnings Per Share, Basic for the twelve months ending March 31, 2024 was -5.06 USD/shares, a 16.3% decline year-over-year.
- Syros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -5.81 USD/shares, a 22.4% increase from 2022.
- Syros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -7.49 USD/shares, a 45.9% increase from 2021.
- Syros Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2021 was -13.8 USD/shares, a 24% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)